The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It is estimated to grow at a CAGR of 12.1% from 2022 to 2030.
Growing Geriatric Population Fuel Asia Pacific Glucose Monitoring Devices Market
Diabetes among the geriatric population is a growing public health burden worldwide. It is a major cause of morbidity and mortality in the aging population that is later largely attributable to various chronic complications. The aging population is poised to become one of the most significant transformations with a heavy impact on the global social and economic level. This population is growing exponentially worldwide. According to the World Health Organization (2022), by 2030, 1 in 6 people will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 or older is expected to triple between 2020 and 2050 to reach 426 million. The number of geriatric populations is expected to grow significantly in Africa, followed by Asia Pacific. Elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly serious in this population. With the increase in the geriatric population, the prevalence of diabetes has increased. Therefore, there is notable demand for glucose monitoring devices.
Asia Pacific Glucose Monitoring Devices Market Overview
The Asia Pacific Glucose Monitoring Devices Market has been segmented into the China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The market growth in China is high attributed to the rising awareness of the diabetes diagnosis. India holds second largest share in terms of continuous glucose monitoring owing to high prevalence of diabetes in the country. The aforementioned factors are responsible for influential growth of Asia Pacific Glucose Monitoring Devices Market in the Asia Pacific region.
Asia Pacific Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Glucose Monitoring Devices Market Segmentation
The Asia Pacific glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.
Based on type, the Asia Pacific glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.
Based on application, the Asia Pacific glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.
Based on testing site, the Asia Pacific glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.
Based on end user, the Asia Pacific glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Asia Pacific glucose monitoring devices market in 2022.
Based on country, the Asia Pacific glucose monitoring devices market is segmented into the China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. China dominated the Asia Pacific glucose monitoring devices market in 2022.
B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Asia Pacific glucose monitoring devices market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 3,386.90 Million |
| Market Size by 2030 | US$ 8,471.46 Million |
| CAGR (2022 - 2030) | 12.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Glucose Monitoring Devices Market is valued at US$ 3,386.90 Million in 2022, it is projected to reach US$ 8,471.46 Million by 2030.
As per our report Asia Pacific Glucose Monitoring Devices Market, the market size is valued at US$ 3,386.90 Million in 2022, projecting it to reach US$ 8,471.46 Million by 2030. This translates to a CAGR of approximately 12.1% during the forecast period.
The Asia Pacific Glucose Monitoring Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Glucose Monitoring Devices Market report:
The Asia Pacific Glucose Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Glucose Monitoring Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Glucose Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Glucose Monitoring Devices Market
